This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. This Genetic Technology TOE depicts recent diagnostic and therapeutic advances across the global healthcare industry. Clinical trial scenario for monoclonal antibody therapies for migraine are also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunitie...

    $250.00
  2. 28 Apr 2017  |  Global

    Top Technologies in Health and Wellness, 2017

    Top technology trends that are likely to have an impact in 2017

    This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Edit...

    $4,950.00
  3. 28 Apr 2017  |  Global

    Innovations in Biomedical Imaging

    The latest issue of Medical and Diagnostic Imaging TOE profiles innovations in biomedical imaging. Some of the profiles covered include magnetic resonance imaging (MRI) for targeted drug delivery, computerized blood flow simulation with MRI scans, next-generation contrast agents, upper extremity MRI modality, tablet-controlled computed tomography s...

    $950.00
  4. This Genetic Technology TOE depicts trends across the skin testing sector. Technology profiles for skin mimicking, tissue models, in vitro testing and tissue engineering approaches are presented. Clinical trials scenario for skin irritation testing is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engi...

    $250.00
  5. The latest issue of the Medical Devices TOE profiles eight innovations spanning the breadth of the MedTech space. These include synthetic surgical adhesives and sealants, non-invasive biomarker analysis for early cancer detection, borate-based bioactive wound dressing, a nanoscale glass for lab-on-a-chip devices, and a wrist worn wearable and healt...

    $950.00
  6. 21 Apr 2017  |  Global

    Advances in Liquid Biopsy Platforms

    This Genetic Technology TOE depicts trends across liquid biopsy platforms. The advent of novel antibody-based and targeted small molecule therapies have greatly improved the management of cancer disease. However, there is a growing need for robust monitoring platforms for enhanced assessment of diseases progression and treatment monitoring in cance...

    $250.00
  7. 14 Apr 2017  |  Global

    Robotics in Drug Discovery

    The introduction of automation and robotics into the drug discovery process has greatly enhanced the ability to explore and identify new drug candidates. Numerous chemical compounds can be manufactured and analyzed in a matter of a couple of weeks. Robotics can run tests on thousands of these compounds on biological samples for potential therapeuti...

    $950.00
  8. This Genetic Technology TOE depicts the current landscape across life sciences sector. 3D tissue microenvironment tests, protein-based drugs manufacturing, skin testing, cosmetics developments, and crowdsourcing for clinical trials are profiled. The corresponding industry interactions are also depicted. The Genetic Technology TechVision Opportunit...

    $250.00
  9. This Genetic Technology TOE profiles recent trends across biopharmaceutical technologies. The corresponding clinical trials are also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive fie...

    $250.00
  10. 31 Mar 2017  |  Global

    Recent FDA-approved Therapeutics

    This Genetic Technology TOE profiles therapeutics that have been recently approved by FDA. The corresponding clinical trials scenario is also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the exp...

    $250.00